chr2-232523817-AC-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001195129.2(PRSS56):c.1066delC(p.Gln356fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000268 in 1,530,482 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000040 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000025 ( 0 hom. )
Consequence
PRSS56
NM_001195129.2 frameshift
NM_001195129.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.82
Genes affected
PRSS56 (HGNC:39433): (serine protease 56) This gene encodes a protein that contains a peptidase S1 domain and possesses trypsin-like serine protease activity. The encoded protein may play a role in eye development, and mutations in this gene are a cause of autosomal recessive posterior microphthalmos. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-232523817-AC-A is Pathogenic according to our data. Variant chr2-232523817-AC-A is described in ClinVar as [Pathogenic]. Clinvar id is 1324965.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr2-232523817-AC-A is described in Lovd as [Pathogenic]. Variant chr2-232523817-AC-A is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRSS56 | NM_001195129.2 | c.1066delC | p.Gln356fs | frameshift_variant | 9/13 | ENST00000617714.2 | NP_001182058.1 | |
PRSS56 | NM_001369848.1 | c.1069delC | p.Gln357fs | frameshift_variant | 9/13 | NP_001356777.1 | ||
PRSS56 | XM_047445431.1 | c.1069delC | p.Gln357fs | frameshift_variant | 9/12 | XP_047301387.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRSS56 | ENST00000617714.2 | c.1066delC | p.Gln356fs | frameshift_variant | 9/13 | 5 | NM_001195129.2 | ENSP00000479745.1 |
Frequencies
GnomAD3 genomes AF: 0.0000399 AC: 6AN: 150426Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
6
AN:
150426
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000254 AC: 35AN: 1379944Hom.: 0 Cov.: 35 AF XY: 0.0000294 AC XY: 20AN XY: 680776
GnomAD4 exome
AF:
AC:
35
AN:
1379944
Hom.:
Cov.:
35
AF XY:
AC XY:
20
AN XY:
680776
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000399 AC: 6AN: 150538Hom.: 0 Cov.: 34 AF XY: 0.0000408 AC XY: 3AN XY: 73506
GnomAD4 genome
AF:
AC:
6
AN:
150538
Hom.:
Cov.:
34
AF XY:
AC XY:
3
AN XY:
73506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Isolated microphthalmia 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 14, 2022 | This sequence change creates a premature translational stop signal (p.Gln356Argfs*148) in the PRSS56 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 248 amino acid(s) of the PRSS56 protein. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the PRSS56 protein in which other variant(s) (p.Arg563Alafs*17) have been determined to be pathogenic (PMID: 31266062; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1324965). This premature translational stop signal has been observed in individual(s) with nanophthalmia (PMID: 33203948). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at